News
Latest News
- 12 May 2020 – Posting of Annual Report and Notice of AGM
- 07 May 2020 – Director of Preclinical Development as panel member for KTN Antimicrobial Resistance Global Expert Mission dissemination seminar
- 06 May 2020 – FT article highlights Coronavirus lessons for the fight against superbugs
- 04 May 2020 – Independent review supports the potential of XF-73
- 29 Apr 2020 – Audited results for the year ended 31 December 2019 and clinical development update
- 08 Apr 2020 – Destiny Pharma featured in Endpoints News
- 02 Apr 2020 – Antibiotic resistance could lead to more covid-19 deaths
- 03 Mar 2020 – Clinical and Business Update
- 21 Feb 2020 – Effectiveness of cancer treatments threatened by rising antibiotic resistance
- 22 Jan 2020 – Proactive interview – Destiny Pharma awaits key inflection point mid-2020 in its antimicrobial Phase 2b clinical trial